Shunsuke Tamaki Selected Research

Shunsuke Tamaki Research Topics

Disease

35	Heart Failure 01/2022 - 10/2004
6	Atrial Fibrillation 12/2022 - 10/2017
6	Hypertension (High Blood Pressure) 01/2021 - 06/2012
5	Fibrosis (Cirrhosis) 10/2017 - 06/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2012
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 02/2019 - 02/2009
3	Left Ventricular Dysfunction 01/2018 - 02/2009
2	Infections 12/2022 - 01/2022
2	Diabetes Mellitus 01/2021 - 01/2019
2	Malnutrition (Nutritional Deficiencies) 01/2021 - 01/2019
2	Ventricular Tachycardia 12/2019 - 12/2015
2	Heart Diseases (Heart Disease) 12/2013 - 09/2012
1	Cardiac Arrhythmias (Arrythmia) 12/2022
1	Death (Near-Death Experience) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Anemia 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Body Weight Changes 01/2020
1	Weight Loss (Weight Reduction) 01/2020
1	Dyslipidemias (Dyslipidemia) 01/2019
1	Synovitis 01/2018
1	Leukemia 09/2014
1	Abdominal Aortic Aneurysm 01/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2011
1	Sudden Death 10/2007
1	Ventricular Remodeling 12/2006
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2006

Drug/Important Bio-Agent (IBA)

10	3-Iodobenzylguanidine (Iobenguane)IBA 01/2022 - 10/2007
7	Iodine-123IBA 01/2022 - 10/2007
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2019
4	C-Reactive ProteinIBA 12/2022 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 12/2006
2	NitrogenIBA 01/2022 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 01/2019
2	CreatinineIBA 01/2022 - 06/2011
2	ChloridesIBA 01/2022 - 01/2018
2	Eplerenone (Inspra)FDA LinkGeneric 01/2022 - 10/2017
2	Tolvaptan FDA Link 01/2020 - 04/2017
2	Cholinesterases (Cholinesterase)IBA 01/2020 - 01/2019
2	DiureticsIBA 01/2020 - 04/2017
2	Angiotensin Receptor AntagonistsIBA 01/2019 - 01/2018
2	Angiotensin IIIBA 12/2013 - 01/2013
2	EnzymesIBA 01/2013 - 09/2012
2	Atorvastatin (Lipitor)FDA Link 06/2007 - 12/2006
1	BilirubinIBA 12/2022
1	TransferasesIBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2022
1	tyramine-deoxysorbitolIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 04/2021
1	Serum AlbuminIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	empagliflozinIBA 01/2021
1	HDL CholesterolIBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 11/2020
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019
1	AlbuminsIBA 01/2019
1	SodiumIBA 01/2019
1	candesartanIBA 01/2018
1	azilsartanIBA 01/2018
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2017
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 09/2014
1	Peptide Elongation Factors (Elongation Factor)IBA 09/2014
1	Lysine (L-Lysine)FDA Link 09/2014
1	LigandsIBA 09/2014
1	GlucocorticoidsIBA 09/2014
1	SaltsIBA 12/2013
1	Interleukin-16 (Interleukin 16)IBA 01/2013
1	Neutralizing AntibodiesIBA 01/2013
1	ImmunosorbentsIBA 01/2013
1	Carnitine (L-Carnitine)FDA LinkGeneric 09/2012
1	Arachidonic Acid (Vitamin F)IBA 09/2012
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 09/2012
1	Antihypertensive Agents (Antihypertensives)IBA 09/2012
1	Fatty Acid DesaturasesIBA 09/2012
1	Ouabain (G Strophanthin)IBA 06/2012
1	digoxin-like factorsIBA 06/2012
1	SEA 0400IBA 06/2012
1	Radioisotopes (Radionuclides)IBA 10/2004

Therapy/Procedure

6	Therapeutics 01/2021 - 12/2006
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 12/2019 - 12/2015
1	Patient Readmission 10/2021
1	Catheter Ablation 01/2020
1	Debridement 01/2018
1	Defibrillators (Defibrillator) 06/2015
1	Endovascular Aneurysm Repair 01/2014
1	Nephrectomy 12/2013